Authentication Vulnerability in Algo Edge Component by Roche Diagnostics
CVE-2024-13026

6.1MEDIUM

Key Information:

Vendor

Roche Diagnostics

Status
Algorithm Suite
Vendor
CVE Published:
17 January 2025

What is CVE-2024-13026?

An authentication vulnerability has been identified in the Algo Edge component, which is part of the navify® Algorithm Suite, used in laboratory networks. This vulnerability affects versions up to 2.1.1 and allows an attacker with adjacent network access to potentially craft valid authentication tokens, thus gaining unauthorized access to the Algo Edge system. Other components of the navify® Algorithm Suite remain unaffected. Organizations utilizing this software should evaluate their security posture and consider updating to mitigate potential risks.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Algorithm Suite 0 < 2.1.2

References

https://diagnostics.roche.com/content/dam/diagnostics/Blu...
vendor-advisory

CVSS V4

Score:
6.1
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
High
Availability:
High
Attack Vector:
Adjacent Network
Attack Complexity:
High
Attack Required:
Physical
Privileges Required:
Undefined
User Interaction:
None

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.